Global Hydrocortisone Oral Tablets Market Size, Share, and Trends Analysis Report, By Application (Autoimmune Disease, Adrenal Insufficiency, Arthritis, and Asthma) and By Distribution Channel (Hospital Pharmacies, and Retail Drug Stores), Forecast (2022-2028)

The global hydrocortisone oral tablets market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). Hydrocortisone oral tablets are the corticosteroid medication used for the treatment of swelling and inflammation in adrenal insufficiency, arthritis, and asthma. It is also used for the treatment of autoimmune diseases. The major factor attributing to the growth of the global hydrocortisone oral tablets market includes the rising prevalence of adrenal insufficiency across the globe. According to the National Institute of Health (NIH), adrenal insufficiency is a rare disease affecting around 100 to 140 in every million people across the globe. Secondary adrenal insufficiency is a more common disease affecting around 150 to 280 in every million people globally. Additionally, the use of hydrocortisone oral tablets is also increasing in the treatment of swelling & inflammation due to arthritis. According to the Centers for Disease Control and Prevention (CDC), around 58.5 million people are affected by arthritis in the US in 2020, representing around 24% of the total adult population of the US.

The application of hydrocortisone oral tablets in the treatment of swelling & inflammation is also increasing due to rising cases of asthma across the globe. According to the report published by the World Health Organization (WHO) in May 2021, asthma is one of the major non-communicable diseases that can affect both adults and children. Around 262 million people were affected by asthma globally in 2019. The estimated mortality caused due to asthma is around 4,61,000 across the globe in 2019. Furthermore, the application of hydrocortisone oral tablets in the treatment of autoimmune diseases is increasing due to the rising prevalence of autoimmune diseases across the globe. According to the National Stem Cell Foundation (NSCF), it is estimated that around 4% of the global total population is affected by any one type of autoimmune disease including some common types of autoimmune diseases including type-1 diabetes, multiple sclerosis, lupus, psoriasis, and scleroderma. Thus, increasing the demand for hydrocortisone oral tablets.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Pfizer Inc., Amneal Pharmaceuticals Inc., Strides Pharma Science Ltd., Flynn Pharma Ltd., and Wellona Pharma, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Hydrocortisone Oral Tablets Market Report by Segment

By Application

• Autoimmune Disease
• Adrenal Insufficiency
• Asthma
• Arthritis

By Distribution Channel

• Hospital Pharmacies
• Retail Drug Stores

Global Hydrocortisone Oral Tablets Market Report by Region

North America

• The United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa